Artigo Revisado por pares

CANCER RECURRENCE AND SURVIVAL RATES AFTER ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY FOR PROSTATE CANCER

1998; Lippincott Williams & Wilkins; Volume: 160; Issue: 6 Part 2 Linguagem: Inglês

10.1016/s0022-5347(01)62204-3

ISSN

1527-3792

Autores

William J. Catàlona, DEBORAH S. SMITH,

Tópico(s)

Urologic and reproductive health conditions

Resumo

No AccessJournal of UrologyFestschrift in Honor of 85th Birthday of Dr. William Wallace Scott, Sr1 Dec 1998CANCER RECURRENCE AND SURVIVAL RATES AFTER ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY FOR PROSTATE CANCERINTERMEDIATE-TERM RESULTS WILLIAM J. CATALONA, and DEBORAH S. SMITH WILLIAM J. CATALONAWILLIAM J. CATALONA , and DEBORAH S. SMITHDEBORAH S. SMITH View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)62204-3AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: We evaluate cancer recurrence and survival rates following anatomic radical retropubic prostatectomy. Materials and Methods: From 1983 through August 1997, 1 surgeon performed anatomic radical retropubic prostatectomy in 1,778 men (mean age plus or minus standard deviation 63 +/− 7), using a unilateral or bilateral nerve sparing modification when feasible (93%). Postoperative adjuvant radiation therapy (mean dose 60 Gy.) was given to 4% of patients because of adverse pathological findings. Patients were followed with semiannual prostate specific antigen (PSA) tests and annual digital rectal examinations. Followup PSA 0.3 ng./ml. or greater was considered evidence of cancer recurrence. We used Kaplan-Meier product limit estimates to calculate 7-year cancer recurrence-free probabilities, prostate cancer specific survival and all cause survival (overall, and stratified by age, preoperative PSA, tumor grade and tumor stage). We used multivariate Cox proportional hazards models to determine clinical and pathological parameters that provided unique predictive information about cancer recurrence. Results: The 7-year recurrence-free survival was significantly associated with lower preoperative PSA (estimated probability of nonprogression 76 to 93% for PSA less than 10), nonpalpable, localized clinical stage (79%), lower tumor grade (84 and 68% for well and moderately differentiated, respectively) and localized pathological stage (81% for pT1 or pT2) (all log rank test p <0.0001) but not age at surgery. All predictors except clinical stage and age remained significant within the multivariate model. Controlling for all other predictors, adjuvant radiation therapy in patients with unfavorable pathology was significantly associated with better recurrence-free survival (p = 0.02). The estimated 7-year prostate cancer specific survival rate was 97% and the all cause survival rate was 90%. Cancer specific and all cause survival were significantly associated with lower grade and localized pathological stage (p <0.0001). Conclusions: Anatomic radical retropubic prostatectomy with the nerve sparing modification can be performed with good cancer control. References 1 : Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate1983; 4: 473. Google Scholar 2 : The role of radical prostatectomy in the treatment of prostate cancer. Cancer J. Clin.1992; 42: 212. Google Scholar 3 : Nerve-sparing radical prostatectomy: evaluation of results after 250 patients. J. Urol.1990; 143: 538. Link, Google Scholar 4 : Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy. J. Urol.1993; 150: 905. Link, Google Scholar 5 : Patient selection for, results of, and impact on tumor resection of potency-sparing radical prostatectomy. Urol. Clin. N. Amer.1990; 17: 819. Google Scholar 6 : Serum PSA after anatomic radical prostatectomy. Urol. Clin. N. Amer.1993; 20: 713. Google Scholar 7 : Prostate-specific antigen after anatomic radical retropubic prostatectomy. Urol. Clin. N. Amer.1997; 24: 395. Google Scholar 8 : 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J. Urol.1994; 152: 1837. Link, Google Scholar 9 : Nerve-sparing radical retropubic prostatectomy. Urol. Clin. N. Amer.1985; 12: 187. Google Scholar 10 : Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J. Urol.1994; 152: 1843. Abstract, Google Scholar 11 : Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer. Urology1997; 50: 93. Google Scholar 12 : Survival after radical prostatectomy. J.A.M.A.1997; 278: 44. Google Scholar 13 : Population-based study of long-term survival in patients with clinically localised prostate cancer. Lancet1997; 349: 906. Google Scholar 14 : Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. J.A.M.A.1993; 270: 948. Google Scholar 15 : The nature of prostate cancers detected through prostate specific antigen-based screening. J. Urol.1994; 152: 1732. Link, Google Scholar 16 : Prospective characterization of pathologic features of prostatic carcinomas detected via serum prostate specific antigen-based screening. J. Urol.1996; 155: 816. Link, Google Scholar 17 : Long-term results of radical retropubic prostatectomy in men with high grade carcinoma of the prostate. J. Urol.1997; 158: 1460. Link, Google Scholar 18 : Results of radical prostatectomy in men with clinically localized prostate cancer. J.A.M.A.1996; 276: 615. Google Scholar From the Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri(CATALONA) Requests for reprints: Division of Urologic Surgery, Campus Box 8242, 4960 Children's Place, St. Louis, Missouri 63110.© 1998 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited ByEllison J, He C and Wood D (2018) Early Postoperative Urinary and Sexual Function Predicts Functional Recovery 1 Year after ProstatectomyJournal of Urology, VOL. 190, NO. 4, (1233-1239), Online publication date: 1-Oct-2013.Shepard D, Dreicer R, Garcia J, Elson P, Magi-Galluzzi C, Raghavan D, Stephenson A and Klein E (2018) Phase II Trial of Neoadjuvant Nab-Paclitaxel in High Risk Patients With Prostate Cancer Undergoing Radical ProstatectomyJournal of Urology, VOL. 181, NO. 4, (1672-1677), Online publication date: 1-Apr-2009.Whittemore D, Hick E, Carter M, Moul J, Miranda-Sousa A and Sexton W (2018) Significance of Tertiary Gleason Pattern 5 in Gleason Score 7 Radical Prostatectomy SpecimensJournal of Urology, VOL. 179, NO. 2, (516-522), Online publication date: 1-Feb-2008.Pavlovich C, Trock B, Sulman A, Wagner A, Mettee L and Su L (2018) 3-Year Actuarial Biochemical Recurrence-Free Survival Following Laparoscopic Radical Prostatectomy: Experience From a Tertiary Referral Center in the United StatesJournal of Urology, VOL. 179, NO. 3, (917-922), Online publication date: 1-Mar-2008.Kibel A, Rosenbaum E, Kattan M, Picus J, Dreicer R, Klein E, Chatta G, Nelson J, DiPaola R, Roth B, Cookson M, Wilding G, Jarrard D, Beer T, Ryan C, Petrylak D, Benson M, Partin A, Garrett-Mayer E and Eisenberger M (2018) Adjuvant Weekly Docetaxel for Patients With High Risk Prostate Cancer After Radical Prostatectomy: A Multi-Institutional Pilot StudyJournal of Urology, VOL. 177, NO. 5, (1777-1781), Online publication date: 1-May-2007.KOUTROUVELIS P, THEODORESCU D, KATZ S, LAILAS N and HENDRICKS F (2018) BRACHYTHERAPY OF PROSTATE CANCER AFTER COLECTOMY FOR COLORECTAL CANCER: PILOT EXPERIENCEJournal of Urology, VOL. 173, NO. 1, (82-86), Online publication date: 1-Jan-2005.RASSWEILER J, SCHULZE M, TEBER D, MARRERO R, SEEMANN O, RUMPELT J and FREDE T (2018) LAPAROSCOPIC RADICAL PROSTATECTOMY WITH THE HEILBRONN TECHNIQUE: ONCOLOGICAL RESULTS IN THE FIRST 500 PATIENTSJournal of Urology, VOL. 173, NO. 3, (761-764), Online publication date: 1-Mar-2005.GRUBB R, ROEHL K, ANTENOR J and CATALONA W (2018) RESULTS OF COMPLIANCE WITH PROSTATE CANCER SCREENING GUIDELINESJournal of Urology, VOL. 174, NO. 2, (668-672), Online publication date: 1-Aug-2005.TEWARI A, JOHNSON C, DIVINE G, CRAWFORD E, GAMITO E, DEMERS R and MENON M (2018) LONG-TERM SURVIVAL PROBABILITY IN MEN WITH CLINICALLY LOCALIZED PROSTATE CANCER: A CASE-CONTROL, PROPENSITY MODELING STUDY STRATIFIED BY RACE, AGE, TREATMENT AND COMORBIDITIESJournal of Urology, VOL. 171, NO. 4, (1513-1519), Online publication date: 1-Apr-2004.SAN FRANCISCO I, REGAN M, OLUMI A and DeWOLF W (2018) PERCENT OF CORES POSITIVE FOR CANCER IS A BETTER PREOPERATIVE PREDICTOR OF CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY THAN PROSTATE SPECIFIC ANTIGENJournal of Urology, VOL. 171, NO. 4, (1492-1499), Online publication date: 1-Apr-2004.RAMOS C, ROEHL K, ANTENOR J, HUMPHREY P and CATALONA W (2018) PERCENT CARCINOMA IN PROSTATECTOMY SPECIMEN IS ASSOCIATED WITH RISK OF RECURRENCE AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH PATHOLOGICALLY ORGAN CONFINED PROSTATE CANCERJournal of Urology, VOL. 172, NO. 1, (137-140), Online publication date: 1-Jul-2004.ROEHL K, HAN M, RAMOS C, ANTENOR J and CATALONA W (2018) CANCER PROGRESSION AND SURVIVAL RATES FOLLOWING ANATOMICAL RADICAL RETROPUBIC PROSTATECTOMY IN 3,478 CONSECUTIVE PATIENTS: LONG-TERM RESULTSJournal of Urology, VOL. 172, NO. 3, (910-914), Online publication date: 1-Sep-2004.HAN M, PARTIN A, ZAHURAK M, PIANTADOSI S, EPSTEIN J and WALSH P (2018) Biochemical (Prostate Specific Antigen) Recurrence Probability Following Radical Prostatectomy for Clinically Localized Prostate CancerJournal of Urology, VOL. 169, NO. 2, (517-523), Online publication date: 1-Feb-2003.GUILLONNEAU B, EL-FETTOUH H, BAUMERT H, CATHELINEAU X, DOUBLET J, FROMONT G and VALLANCIEN G (2018) Laparoscopic Radical Prostatectomy: Oncological Evaluation After 1,000 Cases at Montsouris InstituteJournal of Urology, VOL. 169, NO. 4, (1261-1266), Online publication date: 1-Apr-2003.FABRIZIO M, TÜERK I and SCHELLHAMMER P (2018) Laparoscopic Radical Prostatectomy: Decreasing the Learning Curve Using A Mentor Initiated ApproachJournal of Urology, VOL. 169, NO. 6, (2063-2065), Online publication date: 1-Jun-2003.WARD J, BLUTE M, SLEZAK J, BERGSTRALH E and ZINCKE H (2018) The Long-Term Clinical Impact of Biochemical Recurrence of Prostate Cancer 5 or More Years After Radical ProstatectomyJournal of Urology, VOL. 170, NO. 5, (1872-1876), Online publication date: 1-Nov-2003.HULL G, RABBANI F, ABBAS F, WHEELER T, KATTAN M and SCARDINO P (2018) CANCER CONTROL WITH RADICAL PROSTATECTOMY ALONE IN 1,000 CONSECUTIVE PATIENTSJournal of Urology, VOL. 167, NO. 2 Part 1, (528-534), Online publication date: 1-Feb-2002.KESTIN L, GOLDSTEIN N, VICINI F and MARTINEZ A (2018) Percentage of Positive Biopsy Cores as Predictor of Clinical Outcome in Prostate Cancer Treated With Radiotherapy.Journal of Urology, VOL. 168, NO. 5, (1994-1999), Online publication date: 1-Nov-2002.Kotsis S, Spencer S, Peyser P, Montie J and Cooney K (2018) Early Onset Prostate Cancer: Predictors Of Clinical GradeJournal of Urology, VOL. 167, NO. 4, (1659-1663), Online publication date: 1-Apr-2002.CRITZ F (2018) A STANDARD DEFINITION OF DISEASE FREEDOM IS NEEDED FOR PROSTATE CANCER: UNDETECTABLE PROSTATE SPECIFIC ANTIGEN COMPARED WITH THE AMERICAN SOCIETY OF THERAPEUTIC RADIOLOGY AND ONCOLOGY CONSENSUS DEFINITIONJournal of Urology, VOL. 167, NO. 3, (1310-1313), Online publication date: 1-Mar-2002.Sharkey J, Chovnick S, Behar R, Otheguy J and Rabinowitz R (2018) RE: RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER PROVIDES DURABLE CANCER CONTROL WITH EXCELLENT QUALITY OF LIFE: A STRUCTURED DEBATEJournal of Urology, VOL. 165, NO. 1, (192-193), Online publication date: 1-Jan-2001.CRITZ F, WILLIAMS W, LEVINSON A, BENTON J, HOLLADAY C and SCHNELL F (2018) SIMULTANEOUS IRRADIATION FOR PROSTATE CANCER: INTERMEDIATE RESULTS WITH MODERN TECHNIQUESJournal of Urology, VOL. 164, NO. 3 Part 1, (738-743), Online publication date: 1-Sep-2000.NAM R, ELHAJI Y, KRAHN M, HAKIMI J, HO M, CHU W, SWEET J, TRACHTENBERG J, JEWETT M and NAROD S (2018) SIGNIFICANCE OF THE CAG REPEAT POLYMORPHISM OF THE ANDROGEN RECEPTOR GENE IN PROSTATE CANCER PROGRESSIONJournal of Urology, VOL. 164, NO. 2, (567-572), Online publication date: 1-Aug-2000.HAN M, WALSH P, PARTIN A and RODRIGUEZ R (2018) ABILITY OF THE 1992 AND 1997 AMERICAN JOINT COMMITTEE ON CANCER STAGING SYSTEMS FOR PROSTATE CANCER TO PREDICT PROGRESSION-FREE SURVIVAL AFTER RADICAL PROSTATECTOMY FOR STAGE T2 DISEASEJournal of Urology, VOL. 164, NO. 1, (89-92), Online publication date: 1-Jul-2000.KOHAN A, ARMENAKAS N and FRACCHIA J (2018) THE PERIOPERATIVE CHARGE EQUIVALENCE OF INTERSTITIAL BRACHYTHERAPY AND RADICAL PROSTATECTOMY WITH 1-YEAR FOLLOWUPJournal of Urology, VOL. 163, NO. 2, (511-514), Online publication date: 1-Feb-2000.RAMOS C, CARVALHAL G, SMITH D, MAGER D and CATALONA W (2018) RETROSPECTIVE COMPARISON OF RADICAL RETROPUBIC PROSTATECTOMY AND125 IODINE BRACHYTHERAPY FOR LOCALIZED PROSTATE CANCERJournal of Urology, VOL. 161, NO. 4, (1212-1215), Online publication date: 1-Apr-1999.Gould R (2018) TOTAL CRYOSURGERY OF THE PROSTATE VERSUS STANDARD CRYOSURGERY VERSUS RADICAL PROSTATECTOMY: COMPARISON OF EARLY RESULTS AND THE ROLE OF TRANSURETHRAL RESECTION IN CRYOSURGERYJournal of Urology, VOL. 162, NO. 5, (1653-1657), Online publication date: 1-Nov-1999.RAMOS C, CARVALHAL G, SMITH D, MAGER D and CATALONA W (2018) CLINICAL AND PATHOLOGICAL CHARACTERISTICS, AND RECURRENCE RATES OF STAGE T1C VERSUS T2A OR T2B PROSTATE CANCERJournal of Urology, VOL. 161, NO. 5, (1525-1529), Online publication date: 1-May-1999.CARVALHAL G, SMITH D, RAMOS C, KRYGIEL J, MAGER D, YAN Y and CATALONA W (2018) CORRELATES OF DISSATISFACTION WITH TREATMENT IN PATIENTS WITH PROSTATE CANCER DIAGNOSED THROUGH SCREENINGJournal of Urology, VOL. 162, NO. 1, (113-118), Online publication date: 1-Jul-1999. Volume 160Issue 6 Part 2December 1998Page: 2428-2434 Advertisement Copyright & Permissions© 1998 by American Urological Association, Inc.MetricsAuthor Information WILLIAM J. CATALONA More articles by this author DEBORAH S. SMITH More articles by this author Expand All Advertisement PDF DownloadLoading ...

Referência(s)
Altmetric
PlumX